Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Nov 2025)

Core Insights - Ozempic has emerged as a leading weight loss drug, generating significant sales and market interest [1] Sales Performance - Projected sales for Ozempic are expected to reach $17 billion in 2024 [1] - In the first half of 2025, sales are anticipated to exceed $10 billion [1] Manufacturer Impact - The success of Ozempic is beneficial for its manufacturer, Novo Nordisk A/S [1]